ADVANCED LUNG NEUROENDOCRINE TUMOR

Clinical trials for ADVANCED LUNG NEUROENDOCRINE TUMOR explained in plain language.

Never miss a new study

Get alerted when new ADVANCED LUNG NEUROENDOCRINE TUMOR trials appear

Sign up with your email to follow new studies for ADVANCED LUNG NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Targeted radiation vs. standard pill: new hope for advanced lung carcinoid tumors

Disease control Recruiting now

This study is testing whether a new targeted radiation treatment is better than a standard pill at controlling advanced lung neuroendocrine tumors (also called carcinoid tumors). The new treatment, called lutetium Lu 177 dotatate, is an IV drug that seeks out and delivers radiati…

Matched conditions: ADVANCED LUNG NEUROENDOCRINE TUMOR

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

ADVANCED LUNG NEUROENDOCRINE TUMOR

Get alerted when new ADVANCED LUNG NEUROENDOCRINE TUMOR trials appear

Targeted radiation vs. standard pill: new hope for advanced lung carcinoid tumors